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Abstract: Background:  Spasticity is one of the main complications in post-stroke survivors
leading to difficulties in walking and standing resulting in high levels of disability.
Objective:  The aim of the study was to investigate the effects of deep dry needling on
lower limb spasticity in post-stroke survivors. 
Methods:  A randomized clinical trial conducted in post-stroke survivors who were
assigned to one of two groups: Deep dry needling (intervention group) and sham dry
needling (control group). The primary outcome measures were Modified Modified
Ashworth Scale (MMAS) and functional tests (timed up and go test, 10-meter walk
test). Secondary outcome measures were active ankle dorsi-flexion range of motion
(AROM), passive ankle dorsi-flexion range of motion (PROM), single leg stance test,
and Barthel index. All measurements were assessed at baseline (T0), immediately
after the third session one week later (T1), and one month after the end of the
intervention (T2).
Results:  We recruited 24 patients (71% male; mean age 57±10 years; 26.4±1.8 kg∙m
-2  ; time since event: 25.2±12.5 months). There were significant improvements in
MMAS, timed up and go test, 10-meter walk test, Barthel scale, and PROM (  P  <0.05)
in the intervention group compared to controls across the time-points. There were no
significant improvements in AROM assessments (  P  >0.05).
Conclusions:  Deep dry needling decreases muscle spasticity and improves lower limb
function and gait speed in post-stroke survivors.
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Comments of reviewer 1 Answer to the comment 
It is recommended in abstract section the objective is 
corrected to "The aim of the study was to investigate 
the effects of deep dry needling on lower limb 
dysfunction in post-stroke spastic patients. 
It is corrected.  
It must be declared: 
How many was repeated Timed up and go test for each 
patient, and patients turns on which side, affected side 
or intact side? 
How many was repeated Single leg stance test and 
which limb, affected or intact limb was tested? 
How many was repeated 10-meter walk test? 
It has been added. 
Please explain why ankle ROM were measured in 
sitting position with some flexion of knee? Seems it is 
better to measure in supine position with knee extended 
for evaluating gastrocnemius. 
Sorry It was typo. 
It has been corrected. 
Please identify the region of needling in method 
section? 
It has been done 
Please identify depth of needling? Relevant details and reference are added.  
Please explain in detail how was applied sham DN? It has been added. 
 
 
Comments of reviewer 2 Answer to the comment 
Methods:     
 i) Need to inform the reader stroke types and severity 
whether measured by NIHSS or Fugl-Meyer? 
                ii) Need to inform the reader who measured 
the primary and secondary outcomes at T0, T1 and T2? 
Were they part of the study group or independent i.e. 
blinded? 
                iii) Why were these outcome scales chosen 
and their relevance? It is insufficient just to say 
"relevant and reliable" scales 
Requested details are added.  
As it has been noted the patients had the walking 
ability for at least 10 meters and we also had the FAC 
cut-off value since FAC classifies walking ability both 
indoors and outdoors. 
It has been mentioned that spasticity shows up 
impaired motor activity performance due to 
complications related to walking and standing. These 
outcomes are useful in quantifying advanced functional 




i) Study Limitation: a) Small study sample increases 
the chances for Type I and Type II errors. b) Study is 
still a short duration (4-weeks). 
With regards to the limitations of this study (small 
study sample and short duration (4-weeks) of 
intervention), we recommend that larger, well 
controlled studies are conducted, perhaps in 
conjunction with other rehabilitation therapies, to 
strengthen the evidence-based for dry needling in this 
patient cohort. 
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Abstract 
Background: Spasticity is one of the main complications in post-stroke survivors leading to difficulties in 
walking and standing resulting in high levels of disability. 
Objective: The aim of the study was to investigate the effects of deep dry needling on lower limb 
dysfunction in post-stroke spastic patients.   
Methods: A randomized clinical trial conducted in post-stroke survivors who were assigned to one of two 
groups: Deep dry needling (intervention group) and sham dry needling (control group). The primary 
outcome measures were Modified Modified Ashworth Scale (MMAS) and functional tests (timed up and 
go test, 10-meter walk test). Secondary outcome measures were active ankle dorsi-flexion range of motion 
(AROM), passive ankle dorsi-flexion range of motion (PROM), single leg stance test, and Barthel index. 
All measurements were assessed at baseline (T0), immediately after the third session one week later (T1), 
and one month after the end of the intervention (T2).  
Results: We recruited 24 patients (71% male; mean age 57±10 years; 26.4±1.8 kg∙m-2; time since event: 
25.2±12.5 months). There were significant improvements in MMAS, timed up and go test, 10-meter walk 
test, Barthel scale, and PROM (P<0.05) in the intervention group compared to controls across the time-
points. There were no significant improvements in AROM assessments (P>0.05).  
Conclusions: Deep dry needling decreases muscle spasticity and improves lower limb function and gait 
speed in post-stroke survivors.  
  













Stroke is a serious clinical condition leading to a major cause of long-term disability in survivors.1,2 
According to the World Health Organization, there were 42.4 million post-stroke survivors in 
2015.3,4 Disability affects 75% of post-stroke survivors causing limitations to daily activities and 
reducing quality of life.5 Spasticity is the leading cause of disability in patients affecting 60% of 
the cohort.6 Patients with lower limb spasticity have various difficulties in walking and standing 
resulting in high levels of disability.7,8 Indeed, the spasticity of the lower extremity is associated 
with a reduction in functional independence.9 
Currently, existing therapies for the elimination of spasticity include anti-spasticity drugs such as 
baclofen, dantrolene, tizanidine, and diazepam, which treat the symptoms of the condition and may 
lead to side effects, or in extreme cases, may contribute to increased dysfunction.10–12 The 
emergence of dry needle therapy, a relatively new technique, has recently shown promise.13,14 This 
treatment method is widely used in managing myofascial pain, trigger points, and soft tissue 
injuries including tendinitis.15–18 Dry needling (DN) uses a thin sterile stainless-steel needle, 
without the use of injectate, to penetrate the skin and stimulate trigger points, neural tissue, muscles 
and connective tissue for pain relief and functional improvement.19,20 This stimulation disrupts the 
endplate zone of the nerves and improves blood flow leading to improvements in motor function 
and control.21,20  
In recent years, the use of DN has increased in the treatment of post-stroke survivors.14 According 
to a case report and case series, DN is effective in the upper body of post-stroke survivors for 
improving function.14,22 Further work has shown a positive impact of DN on the gastrocnemius 
and soleus muscle groups in the lower limb following stroke.23,24 However, few randomized 
clinical trials (RCTs) have focused on DN in the lower extremities of post-stroke survivos.25,26 
Longer term studies currently do not exist and, due to the possible placebo effect of dry needling,27 
studies should compare DN to a sham treatment to minimize the risk of bias. Therefore, the aim 
of this randomized clinical trial was to determine the effects of DN on lower limb spasticity and 
dysfunction in post-stroke survivors in the short and longer-term compared to sham treatment. We 
hypothesized that post-stroke survivors receiving three weekly treatment sessions of DN would 
exhibit a greater reduction in spasticity and improvement in function in the short- (one week) and 








A double blind, sham controlled, parallel group, randomized controlled trial. The study protocol was 
approved by the review board, Sports and Exercise Medicine Research Center, and the Ethical Committee 
of Tehran University of Medical Sciences (TUMS) All patients were informed about the study aims and 




The inclusion criteria were: 1) age between 18 and 75 years; 2) first hemiplegic ischemic stroke; 3) stroke 
occurred at least six months prior to trial recruitment; 4) Able to walk without support for at least 10 meters 
5) MMAS spasticity score ≥1; 6) Ambulation ability ≥ 3 based on the Functional Ambulation 
Classification (FAC) test 7) taking no antispasmodic drug; and 8) be able to understand and follow the 
instructions. The exclusion criteria were: 1) have any contraindications to dry needling; 2) have cognitive 
alterations; 3) history of diabetes or neurological pain; 4) fixed muscle contractures at the ankle joint; 5) 







The primary outcome measures were the Modified Modified Ashworth Scale (MMAS), and functional tests 
(timed up and go test, 10-meter walk test). Secondary outcome measures were ankle active extension range 
of motion (AROM), ankle passive extension ROM (PROM), single leg stance test, Barthel index, fascicle 
pennation angle and muscle thickness of the gastrocnemius muscle. All measures were assessed at baseline 
(T0), immediately after the third session of DN (one week; T1), and after one month (T2). The changes in 
mean scores after the intervention were compared between groups at each timepoint.  
 
Procedures 
The baseline characteristics were recorded including sex, age, weight, height, BMI; duration elapsed from 
stroke and hemiplegic side. A qualified sports medicine specialist delivered the DN in three sessions spaced 
across one week, with at least 48 hours between treatment sessions.  
 
Measurements 
Modified Modified Ashworth Scale 
MMAS is an established method for assessing spasticity in post-stroke patients.28,29 A score of ‘0’ indicated 
without an increase in muscle tone; ‘1’ indicated a slight increase in muscle tone, ‘2’ indicated a marked 
increase in muscle tone; ‘3’ indicated considerable increase in muscle tone, passive movement difficult; 
and ‘4’ indicated the affected part rigid in flexion/extension.30 The MMAS has low levels of inter- and 
intra-rater variability in post-stroke patients.31,32 The validity and reliability of the Persian version of the 
MMAS has been previously established.33 Assessment was carried out in a supine position, the assessor 
moved the ankle passively from maximum possible plantar flexion to maximum possible dorsiflexion. 






Timed up and go test 
 
This test is used to evaluate functional ability. The patient is seated in an arm chair and following a 
command from the assessor, the patient must stand, walk 3 meters forward, turning toward the affected 
side, and return to the chair. The time to complete the task is recorded by the assessor. The validity and 
reliability of the test has previously been reported.35 Tests were carried out three times and the best 
performance was used for data analysis. 
 
Single leg stance 
This test measures the ability to stand on one leg and maintain balance. The patient was asked to put their 
hands on the pelvic and try to stand on one leg. The duration the patient could hold the stance was recorded.   
The validity and reliability of the test has been previously reported.36 Tests were performed three times and 
the lowest data was used for analysis. 
 
 
10-meter walk test 
 
This test is used to assess walking speed with the patient being timed during a 10m walk along a corridor. 
Previous work has demonstrated the validity and reliability of the test.37 Three assessments were performed 
and the best time was reported. 
 
Barthel index 
The Barthel questionnaire was used to determine the magnitude of disability and dependency for 
undertaking daily activities. This questionnaire includes 10 items relating to the presence or 
absence of fecal incontinence or urinary incontinence and asks about help needed with grooming, 
toilet use, feeding, transfers (e.g. from chair to bed), walking, dressing, climbing stairs and bathing. 
Scoring is by summing the patient's scores for each item. Possible scores for each question range 
from 0 – 20 and lower scores reveal a greater dependency on others.38 The validity and reliability 








Range of motion 
 
Active and passive ankle dorsiflexion were measured in the supine position with knee extension 
using a standard manual goniometer. The assessor aligned the fulcrum of the device along the 
lateral malleolus, with the stationary arm of the device along the fibula and the moveable arm 




The most common pennate muscle affected by spasticity following stroke is the gastrocnemius 
medialis muscle24 which is the main contributor to gait dysfunction. Muscle architecture (i.e. 
pennation angle and muscle thickness) affects muscle function40 and these factors are often used 
to estimate the amount of force-generating capability.41 Using ultrasonography imaging is a safe, 
cost effective, and non-invasive method for characterizing muscle architecture.24,42 
The gastrocnemius muscle was evaluated via ultrasound imaging (Sonosite MicroMax Ultrasound 
System, Bothell, WA, USA, Real-time, B-mode). The reliability of the fascicle pennation angle 
and muscle thickness of the gastrocnemius muscle has been previously studied.43 To evaluate 
ultrasonographic muscle measurements we asked patients to lie in a prone position, with their feet 
hanging off the bed, but being kept stable via an orthosis at maximum plantar flexion (Figure 
1).44,45 The 5–10-MHz linear transducer was coated with a water-soluble transmission gel and 
positioned at the midpoint of the medial gastrocnemius muscle belly, between the medial and 
posterior borders at 30% of proximal tibial length.46 While taking images, minimal pressure was 
maintained on the skin surface to avoid compression of the muscle fibers. During each session, 
assessments were performed on two occasions for each participant and the average value was 
calculated. 
Medial gastrocnemius muscle thickness was measured from the distance between the superficial 
and deep aponeuroses, and the pennation angle was measured at the fascicular insertion at the deep 




The DN protocol was performed using disposable sterile stainless-steel needles (size, 0.30 mm×50 
mm; SMC, Seoul, Korea) with patients in the prone position with their ankles hanging from the 
bed. The fast-in and fast-out technique was adopted and each muscle was needled for one 
minute.14,22 The depth of needling was determined according to the clinician’s judgment 
(according to the depth of the tissue underling the skin).47 
For DN of the lateral head of the gastrocnemius muscle, a pillow was placed under the patient's 
leg, and the muscle was needled 2 cm lateral to the middle of the proximal segment of a line 
connecting the heel to the popliteal crease. A point located 2 cm medial to the one third of distal 
segment was needled for the medial head of the gastrocnemius muscle (Figure 2).  
 
 
Randomization and blinding 
Patients were allocated to two groups by computer generated randomization in blocks of 20 in a 
1:1 ratio. The patients were randomized to 1 of 2 groups: dry needling (intervention group) and 
sham dry needling (control group). A research assistant not involved in any other part of the study 
opened the sealed opaque envelopes and assigned the patients to their respective treatment group. 
The DN and sham DN was performed by a trained practitioner who was independent to the study.  
The sham treatment was applied exactly at the same area of the standard DN with blunted dry 
needling. Assessment was performed by an independent, experienced physiotherapist who was unaware 
of the allocated intervention. Participants were blinded to the treatment allocation.  
 
Sample size 
The required number of samples was calculated using the following formula: 
 
The sample size for each of the dependent variables was calculated individually and the largest 
number was considered as the sample size for our study. We calculated that the sample size for 
each group should be n=11, which according to the probable rate of loss during the treatment 
period, 10% was added to account for likely attrition rates, therefore n=12 was selected.  
 
Where:  
 = sample size of Group 1= 11  
 = sample size of Group 2= 11  
 = standard deviation of Group 1= 23  
 = standard deviation of Group 2= 22.6  
 = difference in group means=-19.4  
 = ratio n2/n1=1  
Z1-α/2 = two-sided Z value (eg. Z=1.96 for 95% confidence interval).  
Z1-β = power= 85%  
(Group 1 = Control, Group 2 = Intervention group) 
 
Statistical analysis  
Data were entered into the Statistics Package for Social Sciences (SPSS v22; IBM, NY, USA). All 
continuous data was presented as mean ± [standard deviation (SD)]. Data normality was checked 
for each variable by the Kolmogorov-Smirnov test. Baseline characteristics between groups were 
compared using an independent t-test. Differences over time between the experimental and control 
groups were assessed by a 2×3 (group by time) repeated measures analysis of variance. Bonferroni 
post hoc adjustments were carried out where necessary, and partial eta2 (ŋ𝑝
2). Effect sizes were also 
calculated, with 0.25, 0.40, and >0.40 representing small, medium, and large effect sizes, 
respectively.48 P-values less than 0.05 were considered as significantly different.  
 
Results 
Initially 22 post-stroke survivors (71% male; mean age 57±10 years; 26.4±1.8 kg∙m-2; time since 
event: 25.2±12.5 months) were eligible for the study. Patients were randomly assigned to the 
intervention or sham groups (11 participants per group). Patient physical characteristics are 
reported in Table 1. There were no significant differences between groups for any of these 
parameters.  
Timed up and go test (TUG) 
A significant group by time interaction (F (2, 44) =5.118, P<0.001, ŋ𝑝
2=0.189) showed that the two 
groups responded differently to the intervention. Mean TUG test reduced from 33.82 to 25.06 




A statistically significant group-by-time interaction [F (2, 44) = 49.955, P = 0.02, ŋ𝑝
2=0.164) 
showed that the two groups responded differently to the intervention. The mean time to complete 
ten meters improved from 19.1 to 12.2 seconds in the intervention group and was unchanged in 
the controls.  
 
Single leg stance (SLS) 
A significant group-by-time interaction showed that two groups responded differently to the 
intervention [F (2, 44) = 11.941, P<0.001, ŋ𝑝
2=0.351]. A significant main effect was evident [F (2, 
44) = 18.674, P<0.001, ŋ𝑝
2=0.459] showing how the intervention improved SLS.  
 
Active range of motion (AROM) 
A non-significant group-by-time interaction for AROM was not evident showing that the two 
groups were unchanged following the intervention [F (2, 22) = 0.423, P=0.658, ŋ𝑝
2=0.019]. 
 
Passive range of motion (PROM) 
A group-by-time interaction was evident for PROM showing that the two groups responded 
differently to the intervention [F (2, 44) = 13.487, P<0.001, ŋ𝑝
2=0.413]. A mean difference of -5° 
between T0 and T1 (P<0.001), and 0.4° between T1 and T2 (P = 0.723) was evident following 
Bonferroni correction adjustment.   
 
Barthel index 
A significant group-by-time interaction effect showed that the two groups responded differently 
to the intervention [F (2, 44) =22.624, P<0.001, ŋ𝑝
2  =0.538]. The mean Barthel index improved from 
68-78 after one week in the intervention group and was unchanged in the controls. 
Pennation angle 
A significant group-by-time interaction showed that the two groups responded differently to the 
intervention [F (2, 44) = 64.199, P<0.001, ŋ𝑝
2=0.745]. The pennation angle improved from 19.2° 
to 17.0° in the intervention group and was unchanged in the controls.  
 
Muscle thickness 
A significant group-by-time interaction showed that the two groups responded differently to the 
intervention [F (2, 44) = 134.148, P<0.001, ŋ𝑝
2=0.859]. Mean muscle thickness reduced in the 
intervention group and was unchanged in the controls.  
 
Discussion  
We investigated the impact of three sessions of deep DN in the lower limbs of post-stroke 
survivors. Our randomized clinical trial showed that the intervention improved functional mobility, 
gait speed, and passive range of motion and balance in post-stroke survivors. We found a decrease 
in ankle plantar-flexor spasticity in the intervention group which has been reported in previous 
studies.25,26 To our knowledge, only one other study has assessed the impact of  DN over a one-
week intervention period, however, they targeted the shoulder complex.49  
Muscular dysfunction following stroke may cause negative secondary changes due to contractures. 
These changes include a reduction in muscle fiber length, and a decreased number of serial 
sarcomeres within muscle fibers.50,51 Since muscle stiffness is a result of these structural changes,50 
our findings showing an improvement in passive range of motion due to deep DN is encouraging. 
Other investigators has also shown the positive impact of deep DN applications on muscular 
function in post-stroke survivors. 14,22,26 
Patients with spasticity exhibit impaired motor activity performance due to complications related 
to walking and standing.25 Increased walking speed, for example, is related to recovery of muscle 
spasticity.52 Improvements in standing and gait performance as a result of increased foot contact 
have been reported in post-stroke survivors following DN.25 Our findings showing an 
improvement in TUG and ten-meter walking test also confirm the positive impact of DN in this 
patient cohort. Our findings may also explain the improvements in SLS. Moreover, it has been 
suggested that a decrease in muscle spasticity could lead to improved postural changes including 
improved directional control and center of gravity displacement.26 We also found improvements 
in the Barthel index which is associated with an improvement in functional independency 
including walking on a level surface, and ascending and descending stairs.53  
We did not find any improvement in active range of motion which is in agreement with another 
recent study.25 However, other studies have reported improvements in active range of motion 
following deep DN in the upper limb.14,25 The authors cautiously hypothesized that DN improved 
the function of central motor neurons and neural drive, however, there is a lack of empirical 
evidence to support this assertion. It may be that improved function of afferents from treated 
muscles to sensory and premotor areas of the brain due to DN may be responsible for the observed 
motor improvements.47 However, to detect these changes, it is feasible that more than three 
sessions of DN are required. Normally stroke survivors display an increased pennation angle and 
muscle thickness in their affected muscles.54 We have shown that muscle thickness and pennation 
angle can be improved after three sessions of deep DN. Likewise, a recent study showed similar 
improvements in muscle morphology after only one session of DN.55  
In conclusion, deep dry needling decreases muscle spasticity and improves lower limb function 
and gait speed in post-stroke survivors. With regards to the limitations of this study (small study 
sample and short duration (4-weeks) of intervention), we recommend that larger, well controlled 
studies are conducted, perhaps in conjunction with other rehabilitation therapies, to strengthen the 
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Abstract 
Background: Spasticity is one of the main complications in post-stroke survivors leading to difficulties in 
walking and standing resulting in high levels of disability. 
Objective: The aim of the study was to investigate the effects of deep dry needling on lower limb 
dysfunction in post-stroke spastic patients.   
Methods: A randomized clinical trial conducted in post-stroke survivors who were assigned to one of two 
groups: Deep dry needling (intervention group) and sham dry needling (control group). The primary 
outcome measures were Modified Modified Ashworth Scale (MMAS) and functional tests (timed up and 
go test, 10-meter walk test). Secondary outcome measures were active ankle dorsi-flexion range of motion 
(AROM), passive ankle dorsi-flexion range of motion (PROM), single leg stance test, and Barthel index. 
All measurements were assessed at baseline (T0), immediately after the third session one week later (T1), 
and one month after the end of the intervention (T2).  
Results: We recruited 24 patients (71% male; mean age 57±10 years; 26.4±1.8 kg∙m-2; time since event: 
25.2±12.5 months). There were significant improvements in MMAS, timed up and go test, 10-meter walk 
test, Barthel scale, and PROM (P<0.05) in the intervention group compared to controls across the time-
points. There were no significant improvements in AROM assessments (P>0.05).  
Conclusions: Deep dry needling decreases muscle spasticity and improves lower limb function and gait 
speed in post-stroke survivors.  
  













Stroke is a serious clinical condition leading to a major cause of long-term disability in survivors.1,2 
According to the World Health Organization, there were 42.4 million post-stroke survivors in 
2015.3,4 Disability affects 75% of post-stroke survivors causing limitations to daily activities and 
reducing quality of life.5 Spasticity is the leading cause of disability in patients affecting 60% of 
the cohort.6 Patients with lower limb spasticity have various difficulties in walking and standing 
resulting in high levels of disability.7,8 Indeed, the spasticity of the lower extremity is associated 
with a reduction in functional independence.9 
Currently, existing therapies for the elimination of spasticity include anti-spasticity drugs such as 
baclofen, dantrolene, tizanidine, and diazepam, which treat the symptoms of the condition and may 
lead to side effects, or in extreme cases, may contribute to increased dysfunction.10–12 The 
emergence of dry needle therapy, a relatively new technique, has recently shown promise.13,14 This 
treatment method is widely used in managing myofascial pain, trigger points, and soft tissue 
injuries including tendinitis.15–18 Dry needling (DN) uses a thin sterile stainless-steel needle, 
without the use of injectate, to penetrate the skin and stimulate trigger points, neural tissue, muscles 
and connective tissue for pain relief and functional improvement.19,20 This stimulation disrupts the 
endplate zone of the nerves and improves blood flow leading to improvements in motor function 
and control.21,20  
In recent years, the use of DN has increased in the treatment of post-stroke survivors.14 According 
to a case report and case series, DN is effective in the upper body of post-stroke survivors for 
improving function.14,22 Further work has shown a positive impact of DN on the gastrocnemius 
and soleus muscle groups in the lower limb following stroke.23,24 However, few randomized 
clinical trials (RCTs) have focused on DN in the lower extremities of post-stroke survivos.25,26 
Longer term studies currently do not exist and, due to the possible placebo effect of dry needling,27 
studies should compare DN to a sham treatment to minimize the risk of bias. Therefore, the aim 
of this randomized clinical trial was to determine the effects of DN on lower limb spasticity and 
dysfunction in post-stroke survivors in the short and longer-term compared to sham treatment. We 
hypothesized that post-stroke survivors receiving three weekly treatment sessions of DN would 
exhibit a greater reduction in spasticity and improvement in function in the short- (one week) and 








A double blind, sham controlled, parallel group, randomized controlled trial. The study protocol was 
approved by the review board, Sports and Exercise Medicine Research Center, and the Ethical Committee 
of Tehran University of Medical Sciences (TUMS) All patients were informed about the study aims and 




The inclusion criteria were: 1) age between 18 and 75 years; 2) first hemiplegic ischemic stroke; 3) stroke 
occurred at least six months prior to trial recruitment; 4) Able to walk without support for at least 10 meters 
5) MMAS spasticity score ≥1; 6) Ambulation ability ≥ 3 based on the Functional Ambulation 
Classification (FAC) test 7) taking no antispasmodic drug; and 8) be able to understand and follow the 
instructions. The exclusion criteria were: 1) have any contraindications to dry needling; 2) have cognitive 
alterations; 3) history of diabetes or neurological pain; 4) fixed muscle contractures at the ankle joint; 5) 







The primary outcome measures were the Modified Modified Ashworth Scale (MMAS), and functional tests 
(timed up and go test, 10-meter walk test). Secondary outcome measures were ankle active extension range 
of motion (AROM), ankle passive extension ROM (PROM), single leg stance test, Barthel index, fascicle 
pennation angle and muscle thickness of the gastrocnemius muscle. All measures were assessed at baseline 
(T0), immediately after the third session of DN (one week; T1), and after one month (T2). The changes in 
mean scores after the intervention were compared between groups at each timepoint.  
 
Procedures 
The baseline characteristics were recorded including sex, age, weight, height, BMI; duration elapsed from 
stroke and hemiplegic side. A qualified sports medicine specialist delivered the DN in three sessions spaced 
across one week, with at least 48 hours between treatment sessions.  
 
Measurements 
Modified Modified Ashworth Scale 
MMAS is an established method for assessing spasticity in post-stroke patients.28,29 A score of ‘0’ indicated 
without an increase in muscle tone; ‘1’ indicated a slight increase in muscle tone, ‘2’ indicated a marked 
increase in muscle tone; ‘3’ indicated considerable increase in muscle tone, passive movement difficult; 
and ‘4’ indicated the affected part rigid in flexion/extension.30 The MMAS has low levels of inter- and 
intra-rater variability in post-stroke patients.31,32 The validity and reliability of the Persian version of the 
MMAS has been previously established.33 Assessment was carried out in a supine position, the assessor 
moved the ankle passively from maximum possible plantar flexion to maximum possible dorsiflexion. 






Timed up and go test 
 
This test is used to evaluate functional ability. The patient is seated in an arm chair and following a 
command from the assessor, the patient must stand, walk 3 meters forward, turning toward the affected 
side, and return to the chair. The time to complete the task is recorded by the assessor. The validity and 
reliability of the test has previously been reported.35 Tests were carried out three times and the best 
performance was used for data analysis. 
 
Single leg stance 
This test measures the ability to stand on one leg and maintain balance. The patient was asked to put their 
hands on the pelvic and try to stand on one leg. The duration the patient could hold the stance was recorded.   
The validity and reliability of the test has been previously reported.36 Tests were performed three times and 
the lowest data was used for analysis. 
 
 
10-meter walk test 
 
This test is used to assess walking speed with the patient being timed during a 10m walk along a corridor. 
Previous work has demonstrated the validity and reliability of the test.37 Three assessments were performed 
and the best time was reported. 
 
Barthel index 
The Barthel questionnaire was used to determine the magnitude of disability and dependency for 
undertaking daily activities. This questionnaire includes 10 items relating to the presence or 
absence of fecal incontinence or urinary incontinence and asks about help needed with grooming, 
toilet use, feeding, transfers (e.g. from chair to bed), walking, dressing, climbing stairs and bathing. 
Scoring is by summing the patient's scores for each item. Possible scores for each question range 
from 0 – 20 and lower scores reveal a greater dependency on others.38 The validity and reliability 








Range of motion 
 
Active and passive ankle dorsiflexion were measured in the supine position with knee extension 
using a standard manual goniometer. The assessor aligned the fulcrum of the device along the 
lateral malleolus, with the stationary arm of the device along the fibula and the moveable arm 




The most common pennate muscle affected by spasticity following stroke is the gastrocnemius 
medialis muscle24 which is the main contributor to gait dysfunction. Muscle architecture (i.e. 
pennation angle and muscle thickness) affects muscle function40 and these factors are often used 
to estimate the amount of force-generating capability.41 Using ultrasonography imaging is a safe, 
cost effective, and non-invasive method for characterizing muscle architecture.24,42 
The gastrocnemius muscle was evaluated via ultrasound imaging (Sonosite MicroMax Ultrasound 
System, Bothell, WA, USA, Real-time, B-mode). The reliability of the fascicle pennation angle 
and muscle thickness of the gastrocnemius muscle has been previously studied.43 To evaluate 
ultrasonographic muscle measurements we asked patients to lie in a prone position, with their feet 
hanging off the bed, but being kept stable via an orthosis at maximum plantar flexion (Figure 
1).44,45 The 5–10-MHz linear transducer was coated with a water-soluble transmission gel and 
positioned at the midpoint of the medial gastrocnemius muscle belly, between the medial and 
posterior borders at 30% of proximal tibial length.46 While taking images, minimal pressure was 
maintained on the skin surface to avoid compression of the muscle fibers. During each session, 
assessments were performed on two occasions for each participant and the average value was 
calculated. 
Medial gastrocnemius muscle thickness was measured from the distance between the superficial 
and deep aponeuroses, and the pennation angle was measured at the fascicular insertion at the deep 




The DN protocol was performed using disposable sterile stainless-steel needles (size, 0.30 mm×50 
mm; SMC, Seoul, Korea) with patients in the prone position with their ankles hanging from the 
bed. The fast-in and fast-out technique was adopted and each muscle was needled for one 
minute.14,22 The depth of needling was determined according to the clinician’s judgment 
(according to the depth of the tissue underling the skin).47 
For DN of the lateral head of the gastrocnemius muscle, a pillow was placed under the patient's 
leg, and the muscle was needled 2 cm lateral to the middle of the proximal segment of a line 
connecting the heel to the popliteal crease. A point located 2 cm medial to the one third of distal 
segment was needled for the medial head of the gastrocnemius muscle (Figure 2).  
 
 
Randomization and blinding 
Patients were allocated to two groups by computer generated randomization in blocks of 20 in a 
1:1 ratio. The patients were randomized to 1 of 2 groups: dry needling (intervention group) and 
sham dry needling (control group). A research assistant not involved in any other part of the study 
opened the sealed opaque envelopes and assigned the patients to their respective treatment group. 
The DN and sham DN was performed by a trained practitioner who was independent to the study.  
The sham treatment was applied exactly at the same area of the standard DN with blunted dry 
needling. Assessment was performed by an independent, experienced physiotherapist who was unaware 
of the allocated intervention. Participants were blinded to the treatment allocation.  
 
Sample size 
The required number of samples was calculated using the following formula: 
 
The sample size for each of the dependent variables was calculated individually and the largest 
number was considered as the sample size for our study. We calculated that the sample size for 
each group should be n=11, which according to the probable rate of loss during the treatment 
period, 10% was added to account for likely attrition rates, therefore n=12 was selected.  
 
Where:  
 = sample size of Group 1= 11  
 = sample size of Group 2= 11  
 = standard deviation of Group 1= 23  
 = standard deviation of Group 2= 22.6  
 = difference in group means=-19.4  
 = ratio n2/n1=1  
Z1-α/2 = two-sided Z value (eg. Z=1.96 for 95% confidence interval).  
Z1-β = power= 85%  
(Group 1 = Control, Group 2 = Intervention group) 
 
Statistical analysis  
Data were entered into the Statistics Package for Social Sciences (SPSS v22; IBM, NY, USA). All 
continuous data was presented as mean ± [standard deviation (SD)]. Data normality was checked 
for each variable by the Kolmogorov-Smirnov test. Baseline characteristics between groups were 
compared using an independent t-test. Differences over time between the experimental and control 
groups were assessed by a 2×3 (group by time) repeated measures analysis of variance. Bonferroni 
post hoc adjustments were carried out where necessary, and partial eta2 (ŋ𝑝
2). Effect sizes were also 
calculated, with 0.25, 0.40, and >0.40 representing small, medium, and large effect sizes, 
respectively.48 P-values less than 0.05 were considered as significantly different.  
 
Results 
Initially 22 post-stroke survivors (71% male; mean age 57±10 years; 26.4±1.8 kg∙m-2; time since 
event: 25.2±12.5 months) were eligible for the study. Patients were randomly assigned to the 
intervention or sham groups (11 participants per group). Patient physical characteristics are 
reported in Table 1. There were no significant differences between groups for any of these 
parameters.  
Timed up and go test (TUG) 
A significant group by time interaction (F (2, 44) =5.118, P<0.001, ŋ𝑝
2=0.189) showed that the two 
groups responded differently to the intervention. Mean TUG test reduced from 33.82 to 25.06 




A statistically significant group-by-time interaction [F (2, 44) = 49.955, P = 0.02, ŋ𝑝
2=0.164) 
showed that the two groups responded differently to the intervention. The mean time to complete 
ten meters improved from 19.1 to 12.2 seconds in the intervention group and was unchanged in 
the controls.  
 
Single leg stance (SLS) 
A significant group-by-time interaction showed that two groups responded differently to the 
intervention [F (2, 44) = 11.941, P<0.001, ŋ𝑝
2=0.351]. A significant main effect was evident [F (2, 
44) = 18.674, P<0.001, ŋ𝑝
2=0.459] showing how the intervention improved SLS.  
 
Active range of motion (AROM) 
A non-significant group-by-time interaction for AROM was not evident showing that the two 
groups were unchanged following the intervention [F (2, 22) = 0.423, P=0.658, ŋ𝑝
2=0.019]. 
 
Passive range of motion (PROM) 
A group-by-time interaction was evident for PROM showing that the two groups responded 
differently to the intervention [F (2, 44) = 13.487, P<0.001, ŋ𝑝
2=0.413]. A mean difference of -5° 
between T0 and T1 (P<0.001), and 0.4° between T1 and T2 (P = 0.723) was evident following 
Bonferroni correction adjustment.   
 
Barthel index 
A significant group-by-time interaction effect showed that the two groups responded differently 
to the intervention [F (2, 44) =22.624, P<0.001, ŋ𝑝
2  =0.538]. The mean Barthel index improved from 
68-78 after one week in the intervention group and was unchanged in the controls. 
Pennation angle 
A significant group-by-time interaction showed that the two groups responded differently to the 
intervention [F (2, 44) = 64.199, P<0.001, ŋ𝑝
2=0.745]. The pennation angle improved from 19.2° 
to 17.0° in the intervention group and was unchanged in the controls.  
 
Muscle thickness 
A significant group-by-time interaction showed that the two groups responded differently to the 
intervention [F (2, 44) = 134.148, P<0.001, ŋ𝑝
2=0.859]. Mean muscle thickness reduced in the 
intervention group and was unchanged in the controls.  
 
Discussion  
We investigated the impact of three sessions of deep DN in the lower limbs of post-stroke 
survivors. Our randomized clinical trial showed that the intervention improved functional mobility, 
gait speed, and passive range of motion and balance in post-stroke survivors. We found a decrease 
in ankle plantar-flexor spasticity in the intervention group which has been reported in previous 
studies.25,26 To our knowledge, only one other study has assessed the impact of  DN over a one-
week intervention period, however, they targeted the shoulder complex.49  
Muscular dysfunction following stroke may cause negative secondary changes due to contractures. 
These changes include a reduction in muscle fiber length, and a decreased number of serial 
sarcomeres within muscle fibers.50,51 Since muscle stiffness is a result of these structural changes,50 
our findings showing an improvement in passive range of motion due to deep DN is encouraging. 
Other investigators has also shown the positive impact of deep DN applications on muscular 
function in post-stroke survivors. 14,22,26 
Patients with spasticity exhibit impaired motor activity performance due to complications related 
to walking and standing.25 Increased walking speed, for example, is related to recovery of muscle 
spasticity.52 Improvements in standing and gait performance as a result of increased foot contact 
have been reported in post-stroke survivors following DN.25 Our findings showing an 
improvement in TUG and ten-meter walking test also confirm the positive impact of DN in this 
patient cohort. Our findings may also explain the improvements in SLS. Moreover, it has been 
suggested that a decrease in muscle spasticity could lead to improved postural changes including 
improved directional control and center of gravity displacement.26 We also found improvements 
in the Barthel index which is associated with an improvement in functional independency 
including walking on a level surface, and ascending and descending stairs.53  
We did not find any improvement in active range of motion which is in agreement with another 
recent study.25 However, other studies have reported improvements in active range of motion 
following deep DN in the upper limb.14,25 The authors cautiously hypothesized that DN improved 
the function of central motor neurons and neural drive, however, there is a lack of empirical 
evidence to support this assertion. It may be that improved function of afferents from treated 
muscles to sensory and premotor areas of the brain due to DN may be responsible for the observed 
motor improvements.47 However, to detect these changes, it is feasible that more than three 
sessions of DN are required. Normally stroke survivors display an increased pennation angle and 
muscle thickness in their affected muscles.54 We have shown that muscle thickness and pennation 
angle can be improved after three sessions of deep DN. Likewise, a recent study showed similar 
improvements in muscle morphology after only one session of DN.55  
In conclusion, deep dry needling decreases muscle spasticity and improves lower limb function 
and gait speed in post-stroke survivors. With regards to the limitations of this study (small study 
sample and short duration (4-weeks) of intervention), we recommend that larger, well controlled 
studies are conducted, perhaps in conjunction with other rehabilitation therapies, to strengthen the 
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Figure1. Ultrasonographic gastrocnemius muscle measurements  
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Figure 3. Locations for dry needling 
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Table 1 Baseline clinical characteristics of participants (n=24) 
 





Age (year) 57±9.6 58±6.6 55.9±12.1 0.61 
Sex (male/female) 17/7 10/2 7/5 0.18 
BMI (kg∙m-2) 26.4±18 26.5±1.7 26.3±2.1 0.77 
Disease duration (month) 25.2±12.5 23.9±13.2 26.4±12.1 0.47 
Hemiplegic side (left/right) 12/12 6/6 6/6 1.00  
Note: Values expressed as mean± SD unless indicated otherwise; BMI: body mass index. 

















Table 2. Changes in spasticity, range of motion, functional capacity, and quality of ADL in experimental 
and control groups (n=24) at baseline (T0), after completion of the intervention (T1), and 4 weeks later 
(T2).  
 
Variables Experimental Group 
(n=12) 












































































































12.79±.91 12.82±.96 14.90±.84 14.84±.88 14.87±.91 * * 
NOTE. Values are mean + SD. MMAS: Modified Modified Ashworth Scale; TUG: Timed up and go test; 
SLS: Single Leg Stance; AROM: Active Range Of Motion; PROM: Passive Range Of Motion; BI: 




Modified Modified Ashworth Scale (MMAS)  
A repeated measures ANOVA showed a significant group by time interaction (F (2, 44) =11.278, 
P<0.001, ŋ𝑝
2=0.339) demonstrating that the two groups responded differently to the intervention. 
In the experimental group, the MMAS reduced from 2.58 at baseline, to 1.83 following treatment, 
and remained the same one week later, demonstrating a reduction in spasticity. There was no 
change in the control group. A significant time effect [F (2, 44) = 23.532, P<0.001, ŋ𝑝
2=0.517; was 
also evident (Table 3).  
 
Table-3 The Modified Modified Ashworth Scale (MMAS). Scores presented as the median value. 
 Intervention Group (n=12) Control Group (n=12) 
MMAS T0 T1 T2 T0 T1 T2 
0 0 2 (16.7%) 2 (16.7%) 0 0 0 
1 3 (25%) 5 (41.7%) 5 (41.7%) 1 (8.3%) 2 (16.7%) 2 (16.7%) 
2 3 (25%) 4(33.3%) 4 (33.3%) 4 (33.3%) 4 (33.3%) 4 (33.3%) 
3 6 (50%) 1(8.3%) 1 (8.3%) 7 (58.3%) 6 (50%) 6 (50%) 
4 0 0 0 0 0 0 
 
 
